View source for 20250213485. Oral Dosing Glp-1 Compound (Novo Nordisk A/S)

= Oral Dosing of GLP-1 Compounds =

'''Abstract''':
the present invention relates to improved uses of glp-1 peptides in oral therapy.

'''Inventor(s)''': [[:Category:Flemming S. Nielsen of Frederikssund  DK|Flemming S. Nielsen]], [[:Category:Per Sauerberg of Farum  DK|Per Sauerberg]]

'''CPC Classification''': [[:Category:CPC_A61K9/2013|A61K9/2013]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))


[[Category:Patent Applications]]
[[Category:Novo Nordisk A/S]]
[[Category:CPC_A61K9/2013]]
[[Category:Flemming S. Nielsen of Frederikssund  DK]]
[[Category:Per Sauerberg of Farum  DK]]

[https://wikipatents.org/index.php?search=20250213485+rejection&title=Special%3ASearch&wprov=acrw1_-1 Search for rejections for patent application number 20250213485]


<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250213485. Oral Dosing Glp-1 Compound (Novo Nordisk A/S)","name":"20250213485. Oral Dosing Glp-1 Compound (Novo Nordisk A/S)","description":"Patent application abstract and classification for 20250213485 - Oral Dosing Of Glp-1 Compound","datePublished":"2025-07-03","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250213485","name":"Oral Dosing Of Glp-1 Compound","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Novo Nordisk A/S"}]}}
-->